Approvals/TGA/CSL New Zealand EVOGAM Normal Immunoglobulin (human) 16% (3.2 g/20 mL), Injection Solution Vial for Subcutaneous Use

Approved

STANDARD

CSL New Zealand EVOGAM Normal Immunoglobulin (human) 16% (3.2 g/20 mL), Injection Solution Vial for Subcutaneous Use

CSL Behring (Australia) Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 745fc63a73daea2c
Product Name: CSL New Zealand EVOGAM Normal Immunoglobulin (human) 16% (3.2 g/20 mL), Injection Solution Vial for Subcutaneous Use
Artg Id: 204956
Artg Name: CSL New Zealand EVOGAM Normal Immunoglobulin (human) 16% (3.2 g/20 mL), Injection Solution Vial for Subcutaneous Use
Sponsor: CSL Behring (Australia) Pty Ltd
Company Detail Path: /organization/csl-behring-australia-pty-ltd
Artg Date: 2013-01-15
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: LIE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

745fc63a73daea2c

Type

Standard